Showing posts with label homozygous familial hypercholesterolemia (HoFH). Show all posts
Showing posts with label homozygous familial hypercholesterolemia (HoFH). Show all posts
Thursday, July 19, 2012

FDA accepts NDA filing for KYNAMRO to treat HoFH...

›
In continuation of my update on Mipomersen ... Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced,  that the U.S. ...